Related StoriesHSS researchers help identify lupus sufferers at increased threat of issue pregnanciesNew Swedish study queries treatment of feminine infertility with stem cell therapyINVO Bioscience obtains de novo clearance from FDA for INVOcell fertility treatmentSignals emitted by the embryo itself play a role in implantation and therefore can influence implantation rates. In a pilot research the experts measured the cytokine content material of follicular liquid after oocyte collection and traced the fate of the subsequent embryos. ‘The most salient result of these research was the prediction of good quality and implantation level,’ says Dr. Chaouat. ‘The level of granulocyte colony-stimulating aspect in specific follicular liquid samples was correlated with the implantation potential of the corresponding embryo in both organic and hyperstimulated cycles.Sonia Tolani, of the Women’s Center for Cardiovascular Wellness at New York-Presbyterian Medical center, in NEW YORK. ‘There does seem to be a relationship between the timing of hormone therapy and heart disease risk,’ said Tolani, who was not involved in the scholarly study. However, she stressed, that doesn’t mean women should routinely use hormones when menopause starts. For one, studies just like the most recent one don’t prove that early hormone therapy, itself, lowers cardiovascular disease risk; they are able to only show a link between these factors. And, for over a decade, experts have been advising limited use of hormone therapy, the U.S. National Institute of Ageing says. Hormone therapy is usually considered an option limited to women with more serious menopause symptoms, the NIA noted.